Breaking News on Pharmaceutical Technology

Latest news headlines

Products

Suppliers

Contamination leads to EU-wide Viracept recall

07-Jun-2007 - Roche has initiated a recall of its HIV drug Viracept (nelfinavir) right down to the patient level after finding evidence of dangerous contaminants in the tablets.

Extended storage for Teva MS drug

06-Jun-2007 - The market's first non-interferon based drug for the treatment of multiple sclerosis (MS) can now be stored at room temperature for up to a month, following approval from US and EU authorities.

SPI Pharma responds to Roquette's patent claim

05-Jun-2007 - SPI Pharma has denied infringing Roquette Freres mannitol excipient patent and has claimed instead that Roquette's patent is invalid.

Cobra gets DTI grant for oral bid flu, AIDS vaccines

04-Jun-2007 - The UK Department of Trade and Industry (DTI) has awarded £1.1m (€1.62m) to a consortium led by Cobra Biomanufacturing for a project applying the company's ORT-VAC technology to the development of oral vaccines for avian influenza and HIV/AIDS.

Philanthropic Roche shares manufacturing technology with Africa

04-Jun-2007 - Switzerland-based Roche is helping African nations fight the AIDS epidemic by sharing its coveted saquinavir drug-producing technology with two more manufacturers in Ethiopia and Zimbabwe.

Semi-synthetic paclitaxel production starts in Italy

31-May-2007 - Italian company Indena has announced it has invested in a new facility for the semi-synthetic production of a potent cytotoxic active principle.

GMP peptide plant planned downunder

31-May-2007 - A fund to promote biotech collaborations between Australia and New Zealand has awarded a lump sum to two Antipodean firms which will result in a new good manufacturing practice (GMP) compliant peptide manufacturing plant in the under-served Southern Hemisphere.

Alcohol dependence drug shows financial promise

30-May-2007 - Sales of Alkermes's new drug for alcohol dependence are on a high following its release in June last year, and have contributed a hefty portion to the company's coffers.

Vivalis tech fuelling flu vaccine development

30-May-2007 - Biopharma firm Vivalis has announced several licence agreements for its proprietary cell line technology, adding to the list of companies applying the technology to develop and commercialise new human influenza vaccines.

CMO Daiso licences chiral synthesis tech from Harvard

30-May-2007 - The fine chemicals division of Japanese contract manufacturer Daiso has taken out a license to a highly-selective technology used to synthesise chiral molecules.

New president of manufacturing for Eli Lilly

29-May-2007 - Eli Lilly has announced the appointment of Dr Frank Deane as the new president of its manufacturing operations.

CMOs driving disposable demand

29-May-2007 - Contract manufacturing organisations (CMOs) have been pinpointed as a growth driver of single-use biopharmaceutical manufacturing technologies.

YM's revamped MAb facility gets thumbs up

24-May-2007 - YM BioSciences today announced that the upgraded manufacturing facility for the firm's humanized monoclonal antibody (MAb) for the treatment of cancer has successfully passed a series of regulatory reviews.

Acambis brings smallpox vaccine production in-house

24-May-2007 - UK biotech firm Acambis has decided to bring the manufacturing of its soon to be approved smallpox vaccine in-house while its agreement with contract manufacturer Baxter comes to an end.

Alembic seals epilepsy drug delivery deal

24-May-2007 - Indian firm Alembic has landed a licensing deal with biopharma heavyweight UCB to apply the company's novel drug delivery system for a once-a-day version of UCB's market leading epilepsy drug.

Once-a-day pharyngitis drug one step closer

23-May-2007 - The US Food and Drug Administration have finally accepted Advancis Pharmaceutical's new drug application (NDA) for its once daily amoxicillin Pulsys product for tonsillitis and pharyngitis.

International market boosts Dr Reddy's revenue

23-May-2007 - India-based Dr Reddy's Laboratories has boosted its revenue by 168 per cent for the 2006 year, fuelled by a strengthening position in the international market.

New insulin product takes the nasal route

23-May-2007 - A young start-up company is gearing up to challenge the likes of Pfizer by developing a new insulin product, based on its novel nano-based intranasal delivery technology.

Molecular Insight increasing radiopharmaceutical output

22-May-2007 - Molecular Insight Pharmaceuticals is buying a commercial-scale radiopharmaceutical manufacturing facility in Texas for $3m as it moves towards increasing its manufacturing in the increasingly profitable pharmaceutical area.

Anti-animal testing products drive foot care market

22-May-2007 - With alternative methods being developed in a bid to abolish animal testing in skin and eye irritancy tests, it seems the trend for ethical buying has crossed over into the foot care category during the last quarter.

Approvable letter no distraction for Shire's ADHD drug

22-May-2007 - An approvable letter for Shire's long-lasting formulation of its best-selling attention deficit and hyperactivity disorder (ADHD) drug Adderall is not the stumbling block it may appear says the company.

Taro rescued from looming financial crisis

22-May-2007 - A white knight in the form of Indian-based Sun Pharmaceuticals, has rescued an Israeli company from a looming financial crisis by investing more than $400m in the company.

Solvay wins plaudits for renewable epichlorohydrin process

21-May-2007 - Solvay's Epicerol process for manufacturing the chemical intermediate epichlorohydrin from glycerine won the Belgian company the 2007 Glycerine Innovation Award at the Annual Meeting and Expo of the American Oil Chemists' Society earlier this month.

Luck of the Irish brings new biologics base

21-May-2007 - Proposals for the construction of a new small-scale biologics manufacturing plant in Ireland courtesy of pharma heavyweight Pfizer emerged late last week.

Lupin beefs up with Symbiotec steroids joint venture

16-May-2007 - India's Lupin Ltd is ramping up its active pharmaceutical ingredient (API) capability by teaming up with compatriot and corticosteroid specialist Symbiotec Pharmalab Ltd.

Sign up for your free newsletter